Sign inJoin waitlistJoin the waitlist

Jodi Muscal

Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine · Baylor College of Medicine

Credentials: · ·

History

Baylor College of Medicine
Present

Pediatric Hematology/Oncology
Baylor College of Medicine
2007–2010
Pediatrics
2004–2007
Temple University School of Medicine
2000–2004
Duke University

Research

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)
Pediatric Blood & Cancer · 2013 · First of 11 authors · Corresponding · 70 citations
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112)
Clinical Cancer Research · 2013 · 67 citations
Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates
Cancer Chemotherapy and Pharmacology · 2012 · First of 7 authors · 48 citations

Jed Nuchtern
5 papers
Brenda Weigel
4 papers
Arnold Paulino
3 papers
Jack Su
3 papers
Jennifer Dietrich
3 papers
John Hicks
3 papers
Jonathan Pang
3 papers
Norma Quintanilla
3 papers
Patrick Thompson
3 papers · 1 as a fellow
Rajkumar Venkatramani
3 papers
Sanjeev Vasudevan
3 papers
Stacey Berg
3 papers

Clinical trials

A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
Principal investigator · Suspended · Phase 1
SynerGene Therapeutics, Inc.
2014–2027
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2009
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2020–2027